| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029703 Composition for promoting healthy bone structure |
| 04/18/2006 | US7029666 Uses for non-autologous mesenchymal stem cells |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | CA2238710C New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/13/2006 | WO2006039704A2 Pharmaceutical composition and method for treating a joint capsule arthropathy |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038112A1 Use of kinase inhibitors to promote neochondrogenesis |
| 04/13/2006 | WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/13/2006 | WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079536 Calcium receptor modulating compound and use thereof |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079488 Methods of treating and preventing bone loss |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078539 Remedies for tumor in hematopoietic organs |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645566A2 Analogs of parathyroid hormone |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1645271A1 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 04/12/2006 | EP1644740A1 Assessment of skeletal growth using measurements of nt-cnp peptides |
| 04/12/2006 | EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/12/2006 | EP1560826B1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 04/12/2006 | CN1250552C Prepn process of tripterygium extractive |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250276C Drug for curing disease of proplapse of lumbar intervertebral disc |
| 04/12/2006 | CN1250270C Medicinal wine for expelling wind, eliminating dampness, relaxing tendon and stopping pain |
| 04/12/2006 | CN1250268C Fumigant |
| 04/12/2006 | CN1250267C Health-care product for improving sleep and increasing bone density and preparation method |
| 04/12/2006 | CN1250265C Composition for treating osteoporosis |
| 04/12/2006 | CN1250262C Calcified accreting paste for treating hyperosteogeny |
| 04/12/2006 | CN1250258C Usage of one-ingredient fleur root high wine soak liquid |
| 04/12/2006 | CN1250245C Capsule for treating osteonecrosis and bone fracture |
| 04/12/2006 | CN1250227C Aminoglucose hydrochloride medicinal composition |
| 04/12/2006 | CN1250225C Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035796A1 1-(β-D-GLYCOPYRANOSYL)-3-SUBSTITUTED NITROGENOUS HETEROCYCLIC COMPOUND, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF |
| 04/06/2006 | WO2005120158A3 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074116 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074096 anti-cell prolifertive agents; 4-(1,2-diethylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine; cancers, solid tumours, leukemias, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, hemangioma, nephropathies, atheroma, atherosclerosis, restenosis, autoimmune diseases, inflammation |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |